Evidence map›Paper›PMID 41374338›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections.

Bashayer Mohammed Alshehail, Marwan Jabr Alwezzeh, Hussain Humaid Almalki, Amani Alnimr, Haytham Wali, Zainab Al Jamea, Abdullatif S Al Rashed, Mashael Alhajri, Hawra Abdulwahab Abdulaal, Lujain Ali Alanbari and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Bashayer Mohammed AlshehailPharmacy Practice Department, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.ORCID 0000-0003-2372-9462
Marwan Jabr AlwezzehInfectious Disease Division, Internal Medicine Department, King Fahd University Hospital, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.ORCID 0000-0002-4646-6717
Hussain Humaid AlmalkiDepartment of Pharmaceutical Care, Northern Area Armed Forces Hospital, Hafar Al Batin 31991, Saudi Arabia.
Amani AlnimrDepartment of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.ORCID 0000-0001-5105-6002
Haytham WaliPharmacy Practice Department, College of Clinical Pharmacy, King Faisal University, Alahsa 31982, Saudi Arabia.ORCID 0000-0001-6279-3809
Zainab Al JameaPharmaceutical Care Department, King Fahd University Hospital, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.ORCID 0000-0003-4549-2638
Abdullatif S Al RashedDepartment of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
Mashael AlhajriInfectious Disease Division, Internal Medicine Department, King Fahd University Hospital, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
Hawra Abdulwahab AbdulaalCollege of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia.
Lujain Ali AlanbariCollege of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia.
Yazed S AlsowaidaDepartment of Clinical Pharmacy, College of Clinical Pharmacy, Hail University, Hail 81442, Saudi Arabia.ORCID 0000-0002-0450-9846
Abdullah AlamriPharmaceutical Service Department, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Sharifah AlmuthenInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Faten AzaiezInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Saeed AlzahraniDepartment of Urology and Nephrology, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Nawaf ZakariInternal Medicine Department, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Jaber AsiriPharmaceutical Service Department, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Wafa AlanaziPharmaceutical Service Department, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Mohanad BakkarInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Abdulaziz AlfifiInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.
Omar AlzuwayedPharmaceutical Service Department, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.ORCID 0000-0001-5416-9045
Aiman El-SaedKing Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-1781-2203
Salma AlBahraniInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran 34313, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbapenem-resistant Enterobacteralesinfection recurrencemortalityrisk factorsSaudi Arabia

Identifiers

PMID41374338
PMCPMC12691276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.